JP2022515480A5 - - Google Patents
Info
- Publication number
- JP2022515480A5 JP2022515480A5 JP2021537716A JP2021537716A JP2022515480A5 JP 2022515480 A5 JP2022515480 A5 JP 2022515480A5 JP 2021537716 A JP2021537716 A JP 2021537716A JP 2021537716 A JP2021537716 A JP 2021537716A JP 2022515480 A5 JP2022515480 A5 JP 2022515480A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862785316P | 2018-12-27 | 2018-12-27 | |
| US62/785,316 | 2018-12-27 | ||
| US201962815431P | 2019-03-08 | 2019-03-08 | |
| US62/815,431 | 2019-03-08 | ||
| US201962891464P | 2019-08-26 | 2019-08-26 | |
| US62/891,464 | 2019-08-26 | ||
| PCT/EP2019/086521 WO2020136101A1 (en) | 2018-12-27 | 2019-12-20 | Anti-il-36r antibodies for treatment of palmoplantar pustulosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022515480A JP2022515480A (ja) | 2022-02-18 |
| JPWO2020136101A5 JPWO2020136101A5 (https=) | 2022-12-21 |
| JP2022515480A5 true JP2022515480A5 (https=) | 2022-12-21 |
Family
ID=69190739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021537716A Pending JP2022515480A (ja) | 2018-12-27 | 2019-12-20 | 掌蹠膿疱症の処置のための抗ｉｌ－３６ｒ抗体 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20200207862A1 (https=) |
| EP (1) | EP3902604A1 (https=) |
| JP (1) | JP2022515480A (https=) |
| KR (1) | KR20210119407A (https=) |
| CN (1) | CN113301955A (https=) |
| AU (1) | AU2019416727A1 (https=) |
| BR (1) | BR112021010789A2 (https=) |
| CA (1) | CA3124996A1 (https=) |
| CL (1) | CL2021001685A1 (https=) |
| IL (1) | IL284259A (https=) |
| MX (1) | MX2021007807A (https=) |
| PH (1) | PH12021551540A1 (https=) |
| TW (1) | TW202037604A (https=) |
| WO (1) | WO2020136101A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016168542A1 (en) | 2015-04-15 | 2016-10-20 | Anaptysbio, Inc. | Antibodies directed against interleukin 36 receptor (il-36r) |
| CA3093692A1 (en) | 2018-03-14 | 2019-09-19 | Boehringer Ingelheim International Gmbh | Use of anti-il-36r antibodies for treatment of generalized pustular psoriasis |
| BR112021016198A2 (pt) | 2019-03-08 | 2021-11-03 | Boehringer Ingelheim Int | Formulações de anticorpo anti-il-36r |
| EP4182022A1 (en) * | 2020-07-17 | 2023-05-24 | Boehringer Ingelheim International GmbH | Anti-il-36r antibodies for the treatment of neutrophilic dermatoses |
| US20220119538A1 (en) * | 2020-09-30 | 2022-04-21 | Boehringer Ingelheim International Gmbh | Anti-il-36r antibodies for treatment of chronic inflammatory pain |
| CN112094349B (zh) * | 2020-11-04 | 2021-02-09 | 上海华奥泰生物药业股份有限公司 | 靶向于白介素36r的抗体及其制备方法和应用 |
| CA3209006A1 (en) * | 2021-03-04 | 2022-09-09 | Boehringer Ingelheim International Gmbh | Methods for the treatment of gpp |
| BR112023017717A2 (pt) | 2021-05-03 | 2024-01-09 | Boehringer Ingelheim Int | Método para produção de espesolimabe |
| CA3218343A1 (en) * | 2021-05-12 | 2022-11-17 | Anaptysbio, Inc. | Antibody composition |
| EP4370550A1 (en) * | 2021-07-12 | 2024-05-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of il-36 inhibitors for the treatment of netherton syndrome |
| KR20250122528A (ko) * | 2022-12-23 | 2025-08-13 | 아이코사백스, 인크. | 메타뉴모바이러스 융합(f) 단백질에 대한 항체 및 그 용도 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| WO2009040602A1 (en) | 2007-09-25 | 2009-04-02 | Becton Dickinson France | Autoinject0r with deactivating means moveable by a safety shield |
| KR102038310B1 (ko) | 2011-11-16 | 2019-11-01 | 베링거 인겔하임 인터내셔날 게엠베하 | 항 ｉｌ-36ｒ 항체 |
| CH705992A2 (de) | 2012-10-11 | 2013-06-14 | Tecpharma Licensing Ag | Injektionsvorrichtung. |
| WO2016168542A1 (en) * | 2015-04-15 | 2016-10-20 | Anaptysbio, Inc. | Antibodies directed against interleukin 36 receptor (il-36r) |
| CN107660155B (zh) | 2015-04-24 | 2021-02-02 | 艾斯曲尔医疗公司 | 药剂输送装置的子组件和药剂输送装置 |
| CH711066A2 (de) | 2015-05-13 | 2016-11-15 | Tecpharma Licensing Ag | Verbesserte Injektionsvorrichtung. |
| JP6654773B2 (ja) * | 2015-12-25 | 2020-02-26 | 国立大学法人名古屋大学 | インターロイキン３６受容体アンタゴニスト欠損症の治療薬 |
| CA3093692A1 (en) * | 2018-03-14 | 2019-09-19 | Boehringer Ingelheim International Gmbh | Use of anti-il-36r antibodies for treatment of generalized pustular psoriasis |
-
2019
- 2019-12-20 EP EP19842584.5A patent/EP3902604A1/en active Pending
- 2019-12-20 JP JP2021537716A patent/JP2022515480A/ja active Pending
- 2019-12-20 US US16/722,133 patent/US20200207862A1/en not_active Abandoned
- 2019-12-20 WO PCT/EP2019/086521 patent/WO2020136101A1/en not_active Ceased
- 2019-12-20 CA CA3124996A patent/CA3124996A1/en active Pending
- 2019-12-20 AU AU2019416727A patent/AU2019416727A1/en not_active Abandoned
- 2019-12-20 CN CN201980087043.9A patent/CN113301955A/zh active Pending
- 2019-12-20 KR KR1020217023769A patent/KR20210119407A/ko not_active Withdrawn
- 2019-12-20 BR BR112021010789-4A patent/BR112021010789A2/pt not_active Application Discontinuation
- 2019-12-20 MX MX2021007807A patent/MX2021007807A/es unknown
- 2019-12-20 TW TW108147070A patent/TW202037604A/zh unknown
-
2021
- 2021-06-21 IL IL284259A patent/IL284259A/en unknown
- 2021-06-23 CL CL2021001685A patent/CL2021001685A1/es unknown
- 2021-06-26 PH PH12021551540A patent/PH12021551540A1/en unknown
-
2022
- 2022-08-10 US US17/818,723 patent/US20230131364A1/en not_active Abandoned
- 2022-11-10 US US18/054,303 patent/US20230115617A1/en not_active Abandoned